Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age

Cell Transplantation

Volumn 6, Issue 6, 1997, Pages 557-569

  Annett, L E ^a,b   Torres, E M ^a,b   Clarke, D J ^c   Ishida, Y ^d   Barker, R A ^a,b   Ridley, R M ^a,b   Baker, H F ^a,b   Dunnett, S B ^a,b  

^a University of Cambridge   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Amphetamine rotation; Embryonic donor age; Marmosets; Nigral grafts

Indexed keywords

OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FETAL TISSUE TRANSPLANTATION; GESTATIONAL AGE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MARMOSET; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CALLITHRIX; CAUDATE NUCLEUS; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL TISSUE TRANSPLANTATION; GESTATIONAL AGE; GRAFT SURVIVAL; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA;

ANIMALIA; MARMOSETS; PRIMATES; RODENTIA;

EID: 0031455188     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00079-1     Document Type: Article

References (49)

1. Abercrombic, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. Annett, L.E. Functional studies of neural grafts in parkinsonian primates. In: Dunnett, S.B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:71-102.
3. Annett, L.E.; Martel, F.L.; Rogers, D.C.; Ridley, R.M.; Baker, H.F.; Dunnett, S.B. Behavioural assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 125:228-246; 1994.
4. Annett, L.E.; Ridley, R.M. Neural transplantation in primates. In: Dunnett, S.B.; Björklund, A., eds. Neural Transplantation: A practical approach. Oxford: IRL Press; 1992:123-138.
5. Annett, L.E.; Rogers, D.C.; Hernandez, T.D.; Dunnett, S.B. Behavioural analysis of unilateral monoamine depletion in the marmoset. Brain 115:825-856; 1992.
6. Annett, L.E.; Torres, E.M.; Ridley, R.M.; Baker, H.F.; Dunnett, S.B. A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions. Exp. Brain Res. 103:355-371; 1995.
7. Bankiewicz, K.S.; Plunkett, R.J.; Jacobowitz, D.M.; Kopin, I.J.; Oldfield, E.H. Fetal nondopaminergic neural implants in parkinsonian primates. J. Neurosurg. 74:97-104; 1991.
8. Barker, R.A.; Fricker, R.A.; Abrous, D.N.; Fawcett, J.; Dunnett, S.B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 4:173-200; 1995.
9. Björklund, A.; Dunnett, S.B.; Nikkah, G. Nigral transplants in the rat Parkinson model: Functional limitations and strategies to enhance nigro-striatal reconstruction. In: Dunnett, S.B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:47-69.
10. Brundin, P. Dissection, preparation, and implantation of human embryonic brain tissue. In: Dunnett, S.B.; Björklund, A., eds. Neural transplantation: A practical approach. Oxford: IRL Press; 1992:139-160.
11. Brundin, P.; Duan, W.-M.; Sauer, H. Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Dunnett, S.B., Björklund, A., ed. Functional neural transplantation. New York: Raven Press; 1994:9-46.
12. Brundin, P.; Nilsson, O.G.; Strecker, R.E.; Lindvall, O.; Astedt, B.; Björklund, A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65:235-240; 1986.
13. Brundin, P.; Strecker, R.E.; Widner, H.; Clarke, D.J.; Nilsson, O.G.; Åstedt, B.; Björklund, A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70:192-208; 1988.
14. Butler, H.; Juurlink, B.H.J. An atlas for staging mammalian and chick embryos. Boca Raton, FL: CRC Press, Inc.; 1987.
15. Dunnett, S.B.; Annett, L.E. Nigral transplants in primate models of parkinsonism. In: Lindvall, O; Björklund, A.; Widner, H., eds. Intracerebral transplantation in movement disorders. Amsterdam: Elsevier; 1991:27-51.
16. Dunnett, S.B.; Björklund, A. Staging and dissection of rat embryos. In: Dunnett, S.B.; Björklund, A., eds. Neural transplantation: A practical approach. Oxford: IRL Press; 1992:1-19.
17. Dunnett, S.B.; Björklund, A. Functional neural transplantation. New York: Raven Press; 1994.
18. Dunnett, S.B.; Hernandez, T.D.; Summerfield, A.; Jones, G.H.; Arbuthnott, G. Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71:411-424; 1988.
19. Elsworth, J.D.; Redmond, D.E., Jr.; Sladek, J.R., Jr.; Deutch, A.Y.; Collier, T.J.; Roth, R.H. Reversal of MPTP-induced Parkinsonism in primates by fetal dopamine cell transplants. In: Franks, A.J.; Ironside, J.W.; Mindham, R.H.S.; Smith, R.J.; Spokes, E.G.S.; Winlow, W., eds. Function and dysfunction in the basal ganglia. Manchester: Manchester University Press; 1990:161-180.
20. Elsworth, J.D.; Sladek, J.R., Jr.; Taylor, J.R.; Collier, T.J.; Redmond, D.E., Jr.; Roth, R.H. Early gestational mesencephalon grafts but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys. Neuroscience 72:477-484; 1996.
21. Freed, C.R.; Richards, J.B.; Sabol, K.E.; Reite, M.L. Fetal substantia nigra transplants lead to dopamine cell replacement and behavioural improvement in Bonnet monkeys with MPTP induced parkinsonism. In: Beart, P.M.; Woodruff, G.N.; Jackson, D.M., eds. Pharmacology and functional regulation of dopaminergic neurons. London: Macmillan; 1988:353-360.
22. Freeman, T.B.; Olanow, C.W.; Hauser, R.A.; Nauert, G.M.; Smith, D.A.; Borlongan, C.V.; Sanberg, P.R.; Holt, D.A.; Kordower, J.H.; Vingerhoets, F.J.G.; Snow, B.J.; Calne, D.; Gauger, L.L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:379-388; 1995.
23. Freeman, T.B.; Sanberg, P.R.; Nauert, G.M.; Boss, B.D.; Spector, D.; Olanow, C.W.; Kordower, J.H. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 4:141-154; 1995.
24. Freeman, T.B.; Spence, M.S.; Boss, B.D.; Spector, D.H.; Strecker, R.E.; Olanow, C.W.; Kordower, J.H. Development of dopaminergic neurons in the human substantia nigra. Exp. Neurol. 113:344-353; 1991.
25. Henderson, B.T.H.; Clough, C.G.; Hughes, R.C.; Hitchcock, E.R.; Kenny, B.C. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch. Neurol. 48:822-827; 1991.
26. Hendrickx, A.G.; Sawyer, R.H.; Lasley, B.L.; Barnes, R.D. Comparison of developmental stages in primates with a note on the detection of ovulation. In: Perkins, P.T.; O'Donoghue, P.N., eds. Breeding simians for developmental biology, vol 6. London: Laboratory Animal Handbooks. 1975:305-315.
27. Hitchcock, E.H.; Henderson, B.T.H.; Kenny, B.G.; Clough, C.G.; Hughes, R.C.; Detta, A. Stereotactic implantation of foetal mesencephalon. In: Lindvall, O. Björklund, A.; Widner, H.; eds. Intracerebral transplantation in movement disorders. Amsterdam: Elsevier; 1991:79-86.
28. Hitchcock, E.H.; Whitwell, H.L.; Sofroniew, M.V.; Bankiewicz, K.S. Survival of TH-positive and neuromelanincontaining cells in patients with Parkinson's disease after intrastriatal grafting of fetal ventral mesencephalon. Exp. Neurol. 129:3; 1994.
29. Kopyov, O.V.; Jacques, D.S.; Lieberman, A.; Duma, C.M.; Rogers, R.L. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell transplant. 5:327-337; 1996.
30. Kordower, J.H.; Freeman, T.B.; Snow, B.J.; Vingerhoets, F.J.G.; Mufson, E.J.; Sanberg, P.R.; Hauser, R.A.; Smith, D.A.; Nauert, G.M.; Perl, D.P.; Olanow, C.W. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
31. Lindvall, O. Neural transplantation in Parkinson's disease. In: Dunnett, S.B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994: 103-137.
32. Lindvall, O.; Sawle, G.; Widner, H.; Rothwell, J.C.; Björklund, A.; Brooks, D.; Brundin, P.; Frackowiak, R.; Marsden, C.D.; Odin, P.; Rehncrona, S. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:172-180; 1994.
33. Nakao, N.; Frodl, E.M.; Duan, W.-M.; Widner, H.; Brundin, P. Lazaroids improve the survival of grafted rate embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91:12408-12412; 1994.
34. Nakao, N.; Frodl, E.M.; Widner, H.; Carlson, E.; Eggerding, F.A.; Epstein, C.J.; Brundin, P. Overexpressing Cu/Zn Superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:226-231; 1995.
35. Olanow, C.W.; Kordower, J.H.; Freeman, T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:102-109; 1996.
36. O'Rahilly, R.; Müller, F. Developmental stages in human embryos. Washington: Carnegie Institute; 1987.
37. Redmond, D.E., Jr.; Lebranth, C.; Spencer, D.C.; Robbins, R.; Vollmer, T.; Kim, J.H.; Roth, R.H. Fetal neural graft survival. Lancet 336:820-822; 1990.
38. Redmond, D.E., Jr.; Sladek, J.R., Jr.; Roth, R.H.; Collier, T.J.; Elsworth, J.D.; Deutch, A.Y.; Haber, S. Fetal neuronal grafts in monkeys given methylphenylterahydropyridine. Lancet 8490:1125-1127; 1986.
39. 18F]Fluorodopa uptake in five grafted Parkinsonian patients. Ann. Neurol. 38:1580-588; 1995.
40. 18F]6-L-Fluorodopa studies in two patients with putaminal implants. Ann. Neurol. 31:166-173; 1992.
41. Seiger, A.; Olson, L. Quantitation of fiber growth in transplanted central monoamine neurons. Cell Tissue Res. 179:285-316; 1977.
42. Sinclair, S.; Torres, E.M.; Dunnett, S.B. GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport 7:2547-2552; 1996.
43. Sladek, J.R., Jr.; Collier, T.J.; Haber, S.N.; Roth, R.H.; Redmond, D.E., Jr.; Survival and growth of fetal catecholamine neurons transplanted into primate brain. Brain Res. Bull. 17:809-818; 1986.
44. Sladek, J.R., Jr.; Redmond, D.E.; Collier, T.J.; Blount, J.P.; Elsworth, J.D.; Taylor, J.R.; Roth, R.H. Fetal dopamine neural grafts: Extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog. Brain Res. 78:497-506; 1988.
45. Sladek, J.R., Jr.; Elsworth, J.D.; Roth, R.H.; Evans, L.E.; Collier, T.J.; Cooper, S.J.; Taylor, J.R.; Redmond, D.E. Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor age in nonhuman primates. Exp. Neurol. 122:16-27; 1993.
46. Taylor, J.R.; Elsworth, J.D.; Roth, R.H.; Sladek, J.R., Jr.; Collier, T.J.; Redmond, D.E., Jr. Grafting of fetal substantia nigra to striatum reverses behavioural deficits induced by MPTP primates: A comparison with other types of grafts as controls. Exp. Brain Res. 85:335-348; 1991.
47. Taylor, J.R.; Elsworth, J.D.; Roth, R.H.; Sladek, J.R., Jr.; Collier, T.J.; Roth, R.H.; Redmond, D.E., Jr. Sham surgery does not ameliorate MPTP-induced behavioural deficits in monkeys. Cell Transplant. 4:13-26; 1995.
48. Widner, H.; Tetrud, J.; Rehncrona, S.; Snow, B.; Brundin, P.; Gustavii, B.; Björklund, A.; Lindvall, O.; Langston, J.W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1556-1563; 1992.
49. Winer, B.J. Statistical principles in experimental design. New York: McGraw Hill; 1974.